TELA Bio, Inc. Payments of Financing Costs
TELA Bio, Inc. (TELA) reported Payments of Financing Costs of $3.55 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-03-25
- TELA Bio, Inc. payments of financing costs for the quarter ending 2022-12-31 was $0.00.
- TELA Bio, Inc. payments of financing costs for the quarter ending 2022-09-30 was $103.00K.
- TELA Bio, Inc. payments of financing costs for the quarter ending 2018-12-31 was $739.00K.
- TELA Bio, Inc. payments of financing costs for fiscal 2025 was $3.55M.
- TELA Bio, Inc. payments of financing costs for fiscal 2022 was $3.46M.
- TELA Bio, Inc. payments of financing costs for fiscal 2018 was $1.57M, a 163.26% increase from fiscal 2017.
- TELA Bio, Inc. payments of financing costs for fiscal 2017 was $596.00K.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.55M 10-K · filed 2026-03-25 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $103.00K derived: sum of 2 quarters · filed 2025-03-21 | $3.46M 10-K · filed 2025-03-21 | |
| 2022-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.46M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $3.36M 10-Q · filed 2023-08-10 | |||
| 2018-12-31 | $739.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $1.57M 10-K · filed 2021-03-25 | ||
| 2018-09-30 | $830.00K 10-Q · filed 2019-12-18 | |||
| 2017-12-31 | $596.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |